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Class B scavenger receptor type I (SR-BI) is a phosphatidylserine (PS)-recognizing
receptor of testicular Sertoli cells responsible for the phagocytosis of spermatogenic
cells undergoing apoptosis. Here, we determined signal mediators that compose
a signalling pathway for SR-BI-induced phagocytosis. Results of a yeast two-
hybrid analysis and a cell-free binding assay indicated that SR-BI binds to
engulfment adapter protein (GULP) using the C-terminal intracellular domain.
A co-immunoprecipitation analysis showed the existence of a complex of GULP and
SR-BI in cells prior to the activation of SR-BI by PS. A reduction of GULP expression
in phagocytes decreased the SR-BI-mediated phagocytosis of apoptotic cells. Admin-
istration to phagocytes of PS-containing liposomes increased the levels of the
GTP-bound form of Rac1 and the phosphorylated forms of mitogen-activated protein
kinases (MAPK) p38 and extracellular signal-related kinase 1 and 2. Finally, lowering
the expression of GULP abrogated MAPK phosphorylation, and the presence of
MAPK inhibitors reduced the level of GTP-bound Rac1 in PS-activated phagocytes.
These results collectively suggested the following signalling pathway for the
SR-BI-induced phagocytosis: (i) PS-recognizing SR-BI activates associated GULP;
(ii) activated GULP induces MAPK phosphorylation; (iii) activated MAPK increases
GTP-bound Rac1; and (iv) activated Rac1 induces a rearrangement of the actin
cytoskeleton.
Key words: apoptosis, phagocytosis, phosphatidylserine, scavenger receptor, small
G protein.
Abbreviations: CrkII, cell death abnormal-2/chicken tumour virus no. 10 regulator of kinase II; ERK,
extracellular signal-related kinase; GST, glutathione S-transferase; GULP, engulfment adapter protein;
MAPK, mitogen-activated protein kinase(s); PS, phosphatidylserine; siRNA, small interfering RNA; SR-BI,
class B scavenger receptor type I.
Cells that have been induced to undergo apoptosis are
promptly and selectively eliminated by phagocytosis
(1, 2), and this mechanism contributes to the architec-
tural and functional establishment of tissues and organs
during early development, the renewal of tissues in
matured organisms, the regulation of immune responses
including inflammation, and the prevention of illness
caused by invading pathogenic microbes or own cells that
have become harmful (3–5). The phagocytic removal of
apoptotic cells also helps physiologic tissue functions to
proceed effectively: we previously found that the phago-
cytosis of male germ cells that have become apoptotic
during spermatogenic differentiation is required for the
efficient production of sperm (6–8). Apoptotic spermato-
genic cells are phagocytosed by a type of testicular
somatic cell called the Sertoli cell in a manner mediated
by the phagocytosis receptor class B scavenger receptor
type I (SR-BI) (7–10), a multiligand receptor also known
as a receptor for high-density lipoprotein (11). Sertoli
cells recognize apoptotic spermatogenic cells through the
binding of SR-BI to phosphatidylserine (PS) exposed on
the surface of target cells during apoptosis (7–9, 12, 13).
The engagement of SR-BI with PS most likely activates a
signalling pathway leading to the induction of phagocy-
tosis in Sertoli cells. In fact, we found that the phos-
phorylation of mitogen-activated protein kinases (MAPK)
p38 and extracellular signal-related kinase 1 and 2
(ERK1/2) is augmented upon stimulation of SR-BI by
PS, and that this event is necessary for a maximal level
of phagocytosis (14). However, other signal mediators
that compose the signalling pathway activated by SR-BI
remain to be identified.
The genetic studies of Horvitz and his colleagues (15)
have revealed the existence of two partly overlap-
ping pathways for the induction of phagocytosis in
Caenorhabditis elegans phagocytes. One pathway con-
sists of the phagocytosis receptor CED-1, the adaptor
protein CED-6 and the Rho family small G protein
CED-10, while the other is composed of the adaptor
CED-2, the signal mediators CED-5 and CED-12
and CED-10 (15–18); the two pathways seem to converge
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at CED-10 (19). All these CED proteins have counter-
parts in Drosophila and mammals, suggesting that the
two signalling pathways are evolutionally conserved
beyond species (18, 20). In the present study, we exam-
ined which of the two pathways is adopted for the
phagocytosis initiated by SR-BI.
MATERIALS AND METHODS
Materials—The anti-rat SR-BI monoclonal antibody
3D12 and its isotype-matched control 2F2 (mouse IgG1)
were generated and characterized as described pre-
viously (10). 3D12 specifically recognizes and neutralizes
rat SR-BI (no cross-reactivity to mouse SR-BI), while 2F2
generated by the same immunization does not bind to
SR-BI. Polyclonal anti-rat SR-BI (9) and anti-mouse
engulfment adapter protein (GULP) (21) rabbit antisera
were generated as described previously. The monoclonal
anti-SR-BI antibodies were used to detect rat SR-BI in
flow cytometry and immunofluorescence as well as to
antagonize the action of rat SR-BI, while the anti-SR-BI
antiserum was used to detect rat SR-BI in western
blotting. Other antibodies used in this study are as
follows: anti-Rac1 (Upstate Biotechnology, Inc., Lake
Placid, NY, USA), anti-phosphorylated p38 (Cell
Signaling Technology Inc., Beverly, MA, USA), anti-p38
(both the phosphorylated and unphosphorylated forms)
(Cell Signaling Technology Inc.), anti-phosphorylated
ERK1/2 (Cell Signaling Technology Inc.), anti-ERK1/2
(both the phosphorylated and unphosphorylated forms)
(Cell Signaling Technology Inc.), anti-(His)6 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA) and anti-
glutathione S-transferase (GST) (Amersham Biosciences,
Uppsala, Sweden). PS and phosphatidylcholine were
purchased from Avanti Polar Lipids (Alabaster, AL,
USA), and liposomes consisting of phosphatidylcholine
and PS at a molar ratio of 7:3 were prepared as described
(12). SB203580 and U0126, which respectively inhibit
the function of p38 and the phosphorylation of ERK1/2,
were purchased from Calbiochem Novabiochem Corp.
(San Diego, CA, USA) and Cell Signaling Technology
Inc., respectively.
Cells—All experiments involving animals were con-
ducted with the approval of the Committee on Animal
Experimentation of Kanazawa University. J774A.1 cells,
a mouse macrophage cell line, were cultured in DMEM
supplemented with 10% (v/v) heat-inactivated fetal
bovine serum at 378C with 5% (v/v) CO2 in air. For
generating J774A.1 cells ectopically expressing rat SR-BI
(J774[SR-BI]), cells were transfected with the plasmid
vector pRc/CMV (Invitrogen, Carlsbad, CA, USA) con-
taining cDNA for rat SR-BI (13) using Gene PORTER2
(Genlantis, San Diego, CA, USA). Colonies that had
grown in the presence of G418 (Promega, Madison, WI,
USA) were analysed for the cell surface expression of rat
SR-BI using 3D12 by either flow cytometry or immuno-
fluorescence. Three colonies independently isolated
showed almost the same levels of rat SR-BI expression
(data not shown), and cells from one colony were used
throughout this study. HEK293 cells, a human kidney-
derived cell line, were maintained in DMEM supple-
mented with 10% heat-inactivated fetal bovine serum
at 378C with 5% CO2 in air. Thymocytes prepared from
ddY mice (females, 6- to 10-weeks old) were induced to
undergo apoptosis by incubation with dexamethasone
(105 M) in RPMI1640 medium supplemented with 10%
fetal bovine serum, and those cells were efficiently
phagocytosed in a PS-dependent manner, as described
previously (22).
Assay for Interaction of GULP and SR-BI—A yeast
two-hybrid analysis was done using a commercial kit
(Clonetech, Mountain View, CA, USA). In brief, the
plasmid vector pACT2 containing cDNA coding for amino
acid residues 1–8 or amino acid residues 464–509, with
the N-terminus numbered as 1, of rat SR-BI, which
respectively corresponded to the N-terminal and
C-terminal intracellular domains, was introduced into
the Saccharomyces cerevisiae strain PJ69-4a together
with the plasmid vector pGBKT7 containing cDNA
for cell death abnormal-2/chicken tumour virus no. 10
regulator of kinase II (CrkII) or GULP (a gift from
K. Ravichandran, University of Virginia, USA). The
occurrence of binding between protein products of each
plasmid DNA was examined according to the manufac-
turer’s instructions. For a binding assay using recombi-
nant proteins, the intracellular domains of SR-BI (same
as those used in the yeast two-hybrid analysis) tagged
with (His)6 were expressed in and purified from
Escherichia coli, and CrkII and GULP were similarly
prepared from E. coli as proteins fused to GST. GST-
CrkII, GST-GULP and GST alone (10mg) immobilized on
glutathione-Sepharose 4B (Amersham Biosciences) were
incubated with the His-tagged SR-BI proteins (10mg)
in buffer composed of 25 mM Tris–HCl (pH 7.5), 0.1 M
NaCl, 2 mM EDTA and 0.5% (v/v) Triton X-100 for 4 h at
48C. The Sepharose was washed four times with the
same buffer, pelleted and incubated with SDS–PAGE
buffer for 5 min at 1008C followed by centrifugation.
The supernatants were analysed by western blotting
with anti-(His)6 and anti-GST antibodies. For a
co-immunoprecipitation analysis, HEK293 cells were
transfected with pRc/CMV expressing rat SR-BI and
p3XFLAG-CMV-10 (Sigma-Aldrich, St Louis, MO, USA)
expressing FLAG-tagged human GULP by the calcium/
phosphate method. They were subsequently incubated in
the absence and presence of PS-containing liposomes
(0.05 mM) and lysed with a buffer consisting of 10 mM
Tris–HCl (pH7.5), 150 mM NaCl, 1 mM EDTA, 1% (v/v)
NP-40, 0.1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS,
5 mg/ml leupeptin and 5mg/ml aprotinin. The cell lysates
were mixed with protein G-Sepharose (Amersham
Biosciences), and materials bound by the Sepharose
were analysed by western blotting with anti-FLAG
antibody (Sigma-Aldrich).
Assays for Phagocytosis—Phagocytosis reactions were
carried out essentially as described (22). In brief,
J774[SR-BI] cells and apoptotic thymocytes as phagocytes
and targets, respectively, were mixed at a ratio of 1:10
and incubated for 30 min at 378C. The cultures were then
washed with phosphate-buffered saline containing 0.05%
(w/v) trypsin to remove the thymocytes free or attached to
the phagocytes, fixed, stained with haematoxylin and
examined for the occurrence of phagocytosis by light-field
microscopy. For the determination of a role for Rac1,
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J774[SR-BI] cells were transfected with a plasmid
containing cDNA for the dominant negative form of
Rac1 (Rac1N17) (23) (a gift from Y. Takuwa, Kanazawa
University, Japan) or the empty vector pME18S together
with Venus-expressing pCS2 (24) (a gift from
A. Miyawaki, RIKEN, Japan) using FuGENE HD trans-
fection reagent (Roche Diagnostics, Indianapolis, IN,
USA). Phagocytosis reactions using those J774[SR-BI]
cells as phagocytes were carried out as described above,
and the washed phagocytes were treated with the DNA-
binding fluorochrome Hoechest33342 to visualize the
nuclei of engulfed thymocytes followed by examination
under a fluorescence-phase contrast microscope. J774[SR-
BI] cells positive for Venus, a variant of yellow fluores-
cence protein (24), were considered as those expressing
Rac1N17 and examined for the presence of the nuclei of
engulfed thymocytes. In all phagocytosis reactions, the
level of phagocytosis was exhibited as the phagocytic
index: the ratio (in percentage terms) of phagocytes that
have accomplished phagocytosis.
Small Interfering RNA-mediated RNA Interference—
Small interfering RNA (siRNA) for the inhibition of
GULP expression was synthesized using a commercial
kit (Dicer siRNA Generation kit; Genlantis). The region
covering nucleotide positions 348–1019, with the first
nucleotide for the translation start codon numbered as 1,
of mouse GULP cDNA placed in front of the T7 promoter
was synthesized by PCR, and the GULP sequence was
transcribed in vitro and processed by dicer (21). siRNA
containing a sequence of green fluorescence protein was
similarly generated. J774[SR-BI] cells were transfected
with the siRNA for 1–2 days using Gene Silencer reagent
(Genlantis) and used in the subsequent experiments.
Determination of the Levels of Phosphorylated MAPK
and GTP-bound Rac1—J774[SR-BI] cells or HEK293
cells forcedly expressing rat SR-BI and FLAG-tagged
human GULP were incubated in the absence and
presence of PS-containing liposome (0.05 mM), and their
lysates were analysed by western blotting for the level of
phosphorylated MAPK as described previously (14). To
determine the level of the GTP-bound form of Rac1,
J774[SR-BI] cells after incubation with PS-containing
liposomes (0.05 mM) were lysed with 50 mM Tris–
HCl (pH 7.2) buffer containing 0.5 M NaCl, 10 mM
MgCl2, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, 5 mg/ml each of leupeptin and aprotinin and
0.1 mM phenylmethylsulfonyl fluoride, and the lysates
were centrifuged at 18,000g at 48C. The supernatants
were incubated with glutathione-Sepharose containing
p21-activated kinase (25), which preferentially binds to
GTP-bound Rac1 (26), for 45 min at 48C. The Sepharose
was pelleted, washed with 50 mM Tris–HCl (pH7.2)
containing 150 mM NaCl, 10 mM MgCl2, 1% Triton
X-100, 5 mg/ml each of leupeptin and aprotinin and
0.1 mM phenylmethylsulfonyl fluoride, and incubated
with SDS–PAGE buffer for 5 min at 1008C. The proteins
released from the Sepharose were analysed by western
blotting using anti-Rac1 antibody.
Western Blotting—Proteins separated by SDS–PAGE
were transferred to polyvinylidene difluoride membranes
and subsequently reacted with primary antibodies and
alkaline phosphatase-conjugated secondary antibodies.
The signals were visualized after a chemiluminescence
reaction using Immun-Star (Bio-Rad Laboratories,
Hercules, CA, USA), and the data were processed in
Fluor-S MultiImager (Bio-Rad Laboratories).
Data Processing—Data are representative of at least
three independent experiments that yielded similar
results. Data from quantitative analyses were expressed
as the meanSD (n> 3).
RESULTS
Binding of GULP to C-terminal Intracellular Region
of SR-BI—GULP (mammalian homologue of C. elegans
CED-6) and CrkII (homologue of CED-2) are adaptor
molecules presumably located proximal downstream of
membrane-bound receptors in two evolutionally con-
served signalling pathways for the induction of phagocy-
tosis of apoptotic cells. We therefore examined if these
adaptors bind to the intracellular regions of SR-BI. There
are two intracellular domains of rat SR-BI corresponding
to amino acid residues 1–8 and 464–509 with the
N-terminus numbered as 1, and the binding of GULP
and CrkII to these two regions was tested in a yeast two-
hybrid analysis. The results indicated that GULP bound
to the C-terminal region, but not to the N-terminal
region, of SR-BI (Table 1). We were unable to judge CrkII
because an indicator in the two-hybrid analysis became
positive in yeast after the expression of CrkII alone
(Table 1). On the other hand, ELMO (homologue of CED-
12) and Rac1 (homologue of CED-10) were negative for
the binding to the intracellular regions of SR-BI at least
as assessed by the yeast two-hybrid analysis (data not
shown). To confirm the results of the yeast two-hybrid
analysis, the binding of GULP and CrkII to SR-BI was
examined in a cell-free assay using purified recombinant
proteins. GULP and CrkII expressed as proteins fused to
GST were incubated with the N-terminal and C-terminal
intracellular regions of SR-BI tagged with (His)6. The
GST-fused proteins were recovered using glutathione-
Sepharose, and the presence of the (His)6-tagged pro-
teins were examined by western blotting with antibody
recognizing the (His)6 tag. We found that the C-terminal
region of SR-BI was pulled down on incubation with
GST-GULP, while the amount of the N-terminal region
precipitated with GST-GULP was at the background
level (Fig. 1A). In contrast, GST-CrkII did not seem to
Table 1. Summary of yeast two-hybrid analysis for the
binding of SR-BI to GULP and CrkII.
Expression with pACT2a
SR-BI-N SR-BI-C None largeT
Expression with pGBKT7a
CrkII +b + + NDc
GULP – ++ – ND
none – – – –
p53 ND ND – ++
aThe indicated proteins in combination were expressed in yeast:
SR-BI-N, N-terminal 9-amino acid region of rat SR-BI; SR-BI-C,
C-terminal 46-amino acid region of rat SR-BI; largeT, SV40 large T
antigen. bThe level of b-galactosidase expression in yeast is arbitrarily
shown: –, not detected; +, moderate level; ++, higher level. cNot
done.
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bind to either the C-terminal or N-terminal intracellular
region of SR-BI (Fig. 1A). We next examined the
formation of a complex between SR-BI and GULP in
HEK293 cells that forcedly expressed these two proteins.
The level of phosphorylated ERK1/2 was increased after
the incubation with PS-containing liposomes (top panel
in Fig. 1B), indicating that SR-BI acts as a PS receptor in
these cells. A co-immunoprecipitation analysis with
whole-cell lysates confirmed the presence of the complex
(middle panel in Fig. 1B), and its level did not seem to
change before and after the treatment of cells with
PS-containing liposomes (bottom panel in Fig. 1B). These
results collectively showed that GULP binds to the
C-terminal intracellular region of rat SR-BI, and sug-
gested that GULP not CrkII is an adaptor acting prox-
imal downstream of the phagocytosis receptor SR-BI.
Requirement of GULP for SR-BI-mediated
Phagocytosis of Apoptotic Cells—In order to examine
the involvement of GULP in the SR-BI-mediated phago-
cytosis of apoptotic cells, we established an assay for
phagocytosis using a mouse macrophage-derived cell line
that ectopically expressed rat SR-BI as phagocytes. This
cell line, which we named J774[SR-BI], expressed rat SR-
BI at the cell surface (Fig. 2A) and phagocytosed
apoptotic thymocytes in a manner dependent on rat
SR-BI (Fig. 2B). We then examined the phagocytosis of
apoptotic cells by J774[SR-BI] cells in which the expres-
sion of GULP was reduced by siRNA. The introduction of
siRNA containing a sequence of GULP mRNA brought
about a near 50% decrease in the level of phagocytosis,
while siRNA with a control green fluorescence protein
sequence had a marginal effect (Fig. 2C). These results
indicated that the presence of GULP is necessary for the
SR-BI-mediated phagocytosis of apoptotic cells, and
suggested that GULP not only binds to SR-BI but also
transmits a signal for the induction of phagocytosis.
Involvement of Rac1 in SR-BI-mediated Phagocytosis
of Apoptotic Cells—Rac1, a mammalian homologue of
C. elegans CED-10 and a member of the Rho family
of small G proteins, is responsible for the rearrangement
of the actin cytoskeleton that directly leads to engulf-
ment by phagocytes (27–30). We previously showed that
the SR-BI-mediated phagocytosis of apoptotic cells
required the formation of pseudopods through the reor-
ganization of actin filaments (14). The involvement of
Rac1 in the phagocytosis of apoptotic cells by J774
[SR-BI] cells was thus examined. The level of GTP-bound
Rac1 increased when J774[SR-BI] cells were incubated
with either apoptotic thymocytes or PS-containing lipo-
somes (Fig. 3A), and this was abrogated when antibody
antagonizing rat SR-BI was present (Fig. 3B). These
results suggested that PS-recognizing SR-BI enhances
the exchange of GDP and GTP bound by Rac1 or inhibits
the conversion of GTP-bound Rac1 into the GDP-bound
form through the GTP-hydrolysing activity of the GTP-
bound and thus active Rac1 (31). We next examined
whether or not Rac1 is required for the SR-BI-mediated
phagocytosis of apoptotic cells. To do so, J774[SR-BI]
cells were transfected with a plasmid expressing a domi-
nant negative form of Rac1 and used in an assay for
phagocytosis. The results showed that the introduction of
the dominant negative Rac1 caused a significant reduc-
tion of phagocytosis (Fig. 3C). In contrast, the dominant
negative RhoA, another member of the Rho family, had
no effect on the phagocytosis reaction (data not shown).
These results indicated that the action of Rac1 is needed
for the SR-BI-mediated phagocytosis of apoptotic cells.
GULP-regulated Activation of MAPK and MAPK-
mediated Activation of Rac1—We previously reported
that either p38 or ERK1/2 is necessary for the SR-BI-
mediated phagocytosis of apoptotic cells (14). We thus
examined the requirement of GULP for the phosphoryla-
tion of p38 and ERK in J774[SR-BI] cells upon
Fig. 1. Binding of GULP, but not CrkII, to C-terminal
region of SR-BI. (A) GST-fused CrkII or GULP were incu-
bated with (His)6-tagged SR-BI proteins, pulled down with
glutathione-Sepharose, and analysed by western blotting with
anti-(His)6 and anti-GST antibodies. The arrowheads point to
the positions of (His)6-tagged SR-BI proteins, and GST-fused
CrkII and GULP. C, C-terminal 46-amino acid region of
rat SR-BI; N, N-terminal 9-amino acid region of rat SR-BI.
(B) HEK293 cells forcedly expressing SR-BI and FLAG-tagged
GULP were incubated in the presence or absence of PS-
containing liposomes for 10 min, and their whole-cell lysates
(25mg proteins) were analysed by western blotting for the levels
of phosphorylated (P) and both phosphorylated and unphos-
phorylated (total) ERK1/2 (top panel). HEK293 cells transfected
with DNA expressing the indicated proteins were subjected to
a co-immunoprecipitation analysis with anti-SR-BI antibody
(immunoprecipitation) and anti-FLAG antibody (western blot-
ting) (middle panel). HEK293 cells expressing both SR-BI and
FLAG-tagged GULP were incubated with PS-containing lipo-
somes for the indicated periods (PS) or left untreated (none),
and their whole-cell lysates were similarly analysed by
co-immunoprecipitation (bottom panel).
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stimulation by PS-containing liposomes. The incubation
of J774[SR-BI] cells with PS-containing liposomes
brought about an increase in the level of phosphorylated
p38 and ERK, and this effect of the liposomes was
significantly mitigated when the level of GULP expres-
sion was reduced with siRNA (Fig. 4A). Furthermore, the
presence of inhibitors of p38 and ERK abolished the
activation of Rac1 in J774[SR-BI] cells treated with PS-
containing liposomes (Fig. 4B). These results indicated
that the presence of GULP is necessary for the efficient
phosphorylation of p38 and ERK, and that the actions of
p38 and/or ERK are in turn required for the activation of
Rac1.
DISCUSSION
We showed that SR-BI binds to the CED-6 homologue
GULP and functionally interacts with GULP and the
CED-10 homologue Rac1. This suggests that SR-BI
activates a signalling pathway corresponding to the
pathway CED-1–CED-6–CED-10 in C. elegans. We pro-
pose the signalling axis SR-BI–GULP–MAPK–Rac1 for
the SR-BI-mediated phagocytosis of apoptotic cells: PS-
bound SR-BI activates associated GULP; activated GULP
induces the phosphorylation of p38 and/or ERK; acti-
vated MAPK stimulates the production of GTP-bound
Rac1; and activated Rac1 induces the rearrangement of
actin filaments that subsequently leads to phagocytosis.
Although we found that MAPK, p38 and/or ERK1/2, are
located downstream of GULP and upstream of Rac1 in
the SR-BI-initiated pathway, it is not known at present
how these MAPK relate with the other signal mediators
in this pathway. An additional signal mediator most
likely exists between GULP and MAPK because the
adaptor GULP seems unable to phosphorylate MAPK.
Similarly, another molecule like a guanine nucleotide-
exchanging factor or GTPase-activating protein (31) is
necessary proximal upstream of Rac1. In line with our
findings, Seetharam et al. (32) reported that SR-BI when
activated by high-density lipoprotein induces the phos-
phorylation of MAPK, which eventually leads to the
Rac-mediated migration of endothelial cells. Further
investigation will be needed to identify the missing
components and obtain a complete view of the signal-
ling pathway for the induction of SR-BI-mediated
phagocytosis.
PS is the best-characterized marker of phagocytosis
that renders many types of cells susceptible to phagocy-
tosis upon the induction of apoptosis (33, 34). Besides SR-
BI, several PS-recognizing phagocytosis receptors have
been identified. Kim and colleagues reported that like
SR-BI, PS-bound stabilin-2 binds to GULP and transmits
a signal for the induction of phagocytosis (21, 35).
In contrast, another PS receptor BAI1 binds to the
mammalian homologue of CED-12 and transmits a signal
for phagocytosis via the mammalian homologue of CED-5
and Rac1 (36). BAI1 thus appears to activate a pathway
corresponding to the CED-2/CED-5/CED-12–CED-10 axis
Fig. 2. Requirement of GULP for SR-BI-mediated phago-
cytosis of apoptotic cells. (A) J774A.1 cells were transfected
with a plasmid expressing rat SR-BI, and one of the isolated cell
clones was analysed for the surface expression of rat SR-BI by
flow cytometry (left) and immunofluorescence (right) using 3D12
and 2F2. The vertical line in the left panel indicates the mean
fluorescence intensity with no added antibody. In immunofluo-
rescence, fluorescence and phase-contrast views of the same
microscopic filed are shown, and the scale bar indicates 10 mm.
(B) Phagocytosis of apoptotic thymocytes by J774[SR-BI] cells
was examined in the presence of the indicated antibody.
(C) J774[SR-BI] cells were transfected with siRNA containing a
sequence of GULP or green fluorescence protein (GFP), or left
untreated. Those cells were analysed for the levels of GULP and
SR-BI by western blotting (75 mg proteins of whole-cell lysates
were used) (top) and for the phagocytic activity with apoptotic
thymocytes as targets (bottom).
Signalling pathway for SR-BI-Induced phagocytosis 391
Vol. 145, No. 3, 2009
in C. elegans. On the other hand, avb5 integrin (37) and
Mer receptor tyrosine kinase (38), which indirectly
recognize PS with the aid of the bridging molecules
milk fat globule EGF factor 8 (39) and Gas6 (40),
respectively, seem to prefer the pathway CED-2/CED-5/
CED-12–CED-10. These findings suggest that signalling
pathways are defined not by the phagocytosis marker or
eat-me signal, PS in this case, but by the structural
nature of the phagocytosis receptor; that is, which
adaptor GULP (CED-6) or CrkII (CED-2) the receptors
may bind to. There exist more PS-recognizing receptors,
Tim4 (41, 42) and kidney injury molecule-1 (43), as well
as other receptors recognizing phagocytosis markers
other than PS (44) although the signalling pathways
activated by these receptors remain to be characterized.
It is important to identify proteins responsible for
transmitting a phagocytosis-inducing signal initiated by
those receptors and determine which of the two evolu-
tionally conserved pathways the corresponding signalling
pathways belong to. Such efforts will be required to gain
an integrated view of the mechanism by which phago-
cytes start to engulf apoptotic cells.
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Fig. 3. Requirement of Rac1 for SR-BI-mediated phago-
cytosis of apoptotic cells. (A) J774[SR-BI] cells were incu-
bated with apoptotic thymocytes (1:10) or PS-containing
liposomes (PS) for the indicated periods, and their whole-cell
lysates were subjected to an assay for GTP-bound Rac1. The
arrowheads point to the positions of GTP-bound Rac1, and both
GTP-bound and GDP-bound Rac1 (total Rac1). (B) The same
assay shown in A was done in the presence of the indicated
antibody (0.1 mg/ml). (C) J774[SR-BI] cells that had been trans-
fected with a plasmid expressing the dominant-negative form of
Rac1 (Rac1N17) or empty vector were subjected to an assay for
phagocytosis with apoptotic thymocytes as targets.
Fig. 4. GULP-dependent phosphorylation of p38 and ERK,
and MAPK-dependent activation of Rac1. (A) J774A.1
[SR-BI] cells that had been transfected with siRNA containing
a sequence of GULP or green fluorescence protein (GFP), or left
untreated were incubated with PS-containing liposomes for
15 min (for the analysis of p38) or 10 min (for the analysis of
ERK), and their whole-cell lysates (50mg proteins for p38 and
25 mg proteins for ERK) were analysed by western blotting for
the amounts of phosphorylated (P), and both phosphorylated
and unphosphorylated (total) MAPK. (B) J774A.1[SR-BI] cells
were incubated with PS-containing liposomes (PS) in the
presence of SB203580 (2mM) and U0126 (10 mM) (USB) or
solvent alone (DMSO) for 60 min, and their whole-cell lysates
were subjected to an assay for GTP-bound Rac1. The arrow-
heads point to the positions of GTP-bound Rac1, and both GTP-
bound and GDP-bound Rac1 (total Rac1).
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